AOD-9604 has emerged as one of the most promising peptides for individuals seeking effective weight loss solutions. This synthetic peptide, specifically designed to target fat burning without the unwanted effects associated with full growth hormone therapy, has gained significant attention in the fitness and medical communities. Originally developed as a fragment of the human growth hormone (hGH), AOD-9604 represents a targeted approach to fat reduction that many researchers and clinicians consider superior to traditional weight loss methods.
AOD-9604 is a synthetic peptide fragment designed specifically for fat burning and weight loss, offering promising results without the side effects of traditional growth hormone treatments.
What Is AOD-9604?
AOD-9604, also known as AOD 9604 or simply "AOD," stands for Anti-Obesity Drug. It consists of the last 16 amino acids of the growth hormone molecule (hGH fragments 177-191). This peptide was initially researched by Merck & Co. in the 1990s as a potential treatment for obesity, and since then, it has become widely used in peptide therapy protocols for weight management and body recomposition.
Unlike traditional growth hormone treatments that can cause significant side effects including organ enlargement, insulin resistance, and other serious complications, AOD-9604 focuses specifically on lipolysis—the breakdown of stored fat—without stimulating unwanted growth in other tissues. This selective action makes it an attractive option for those who want the fat-burning benefits of growth hormone without the associated risks.
Track your labs and see how your protocol moves your biomarkers.
Track it in the app